Curaleaf Holdings, Inc. (CURLF)
Stock Price Chart
Key Info
| Market Cap | 3.54B |
| Revenue (ttm) | 351.26M |
| Net Income (ttm) | -49.60M |
| Shares Out | 365.33M |
| EPS (ttm) | -0.10 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 21, 2020 |
| Last Price | $9.69 |
| Previous Close | $9.57 |
| Change ($) | 0.12 |
| Change (%) | 1.20% |
| Day's Open | 9.68 |
| Day's Range | 9.30 - 9.88 |
| Day's Volume | 858,871 |
| 52-Week Range | 2.54 - 9.25 |
More Stats
| Market Cap | 3.54B |
| Enterprise Value | n/a |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 365.33M |
| Float | 192.98M |
| EPS (basic) | n/a |
| EPS (diluted) | -0.10 |
| FCF / Share | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | n/a |
| Short Ratio | n/a |
| Short % of Float | n/a |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 10.07 |
| PB Ratio | 6.86 |
| Revenue | 351.26M |
| Operating Income | n/a |
| Net Income | -49.60M |
| Free Cash Flow | n/a |
| Net Cash | n/a |
| Net Cash / Share | n/a |
| Gross Margin | 40.32% |
| Operating Margin | n/a |
| Profit Margin | n/a |
| FCF Margin | n/a |
| ROA | 3.29% |
| ROE | -9.36% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
No financial data available for this stock yet.
Company Profile
Company Details
| Full Name | Curaleaf Holdings, Inc. |
| Country | United States |
| CEO | Joseph F. Lusardi |
Stock Information
| Ticker Symbol | CURLF |
| Stock Exchange | US OTC |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | OTCMKTS: CURLF |
Description
Curaleaf Holdings operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oils for vaporizing, cartridges, concentrates, tinctures, mints, capsules, edibles, and flower pods. The company also provides hemp-based CBD products. As of June 29, 2020, it operated 57 dispensaries, 15 cultivation sites, and 24 processing sites in 18 states. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.